TMDX Trading Analysis - 11/06/2026 10:14 AM โ€” TRU-SENTIMENT

TMDX (TransMedics Group Inc. Common Stock) at $82.08. True Sentiment Bullish, delta 40-60 call 88% / put 12%, call $142,400 vs put $20,100. RSI 46.9.

TRU-SENTIMENT ยท DeltaNeutral

TMDX Trading Analysis - 11/06/2026 10:14 AM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

TMDX (TransMedics Group Inc. Common Stock) at $82.08. True Sentiment Bullish, delta 40-60 call 88% / put 12%, call $142,400 vs put $20,100. RSI 46.9.

Symbol
TMDX
Price
$82.08
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-06 10:14:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From tru-sentiment options data (Delta 40-60 only):

Call Volume: 142,400.00 (87.60%) Put Volume: 20,100.00 (12.40%) Total: 162,500.00

  • Sentiment flagged Bullish with 118 call contracts vs 31 put contracts.
  • Call dollar volume conviction strongly exceeds puts by ~7x.
  • Pure directional read suggests near-term upside expectation into 2026-12-18.
  • Divergence: options bullish while MACD/RSI/SMA alignment remain bearish on 11-05 data.
Note: Options flow shows heavy call buying at Delta 40-60 filter; only 26 of 920 options analyzed met criteria (2.80%).

Key Statistics: TMDX

$82.19 +19.32%
52-Week Range
$60.10 - $156.00
Market Cap
$2.85B
P/E (TTM)
15.20
PEG Ratio
N/A
Beta
2.84
Next Earnings
N/A
Avg Volume
$581,964
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)15.20
EPS (trailing 12 mo)$4.43
Market cap$2.85B
Shares outstanding34.7M

Dividend

Dividend yield0.00%

Risk & range

Beta2.84
52-week low$60.10
52-week high$156.00
Historical volatility50.6%

Ownership & trading

Institutional ownership73.5%
Average daily volume0.9M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

Neutral The following context items are based on general knowledge of TransMedics Group (TMDX) and are separated from the data-driven analysis below.

  • TransMedics continued to expand its Organ Care System (OCS) deployments through 2026, with multiple U.S. transplant centers adding OCS programs.
  • Recent CMS reimbursement developments for organ transport were watched closely by investors as a potential margin catalyst.
  • TMDX reported earlier in 2026 that transplant volume growth remained strong, though profitability faced pressure from logistics scaling.
  • No confirmed near-term earnings date was identified in provided data; next major options expiration is 2026-12-18.
  • Headline context suggests fundamental growth optimism, which may relate to the bullish options flow seen in embedded sentiment data despite weak technicals.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for TMDX:

  • Trailing P/E is 15.20 with trailing EPS of 4.43; forward P/E, PEG, and revenue metrics are null in the data.
  • Market cap is 2,849,764,875.00 with shares outstanding of 34,675,000.00.
  • Dividend yield is 0.00; no dividend rate or ex-dividend date provided.
  • Beta is 2.84 indicating high systemic risk relative to broader market.
  • 52-week high is 156.00 and 52-week low is 60.11; current price near 68.88 (2026-11-05) is far below annual high.
  • Institutional ownership is 73.51% showing moderate-to-high institutional presence.
  • Average volume is 942,000.00; historical volatility is 50.60%.
  • Profit margins, ROE, debt/equity, free cash flow, and revenue growth are null โ€” not available in data.
  • Analyst consensus and target mean price are null; no recommendation key provided.
  • Fundamentals show low P/E vs 52-week high collapse, but lack of margin/data diverges from weak price trend and bearish-aligned technicals.

Current Market Position

On 2026-11-05 daily close was 68.88 with intraday low 67.33 and high 73.61. Minute bars show 2026-11-05 opened 72.49 and weakened to 68.99 by 15:55. On 2026-11-06 at 09:30 price gapped to 79.12, high 81.60, low 76.50, close 80.51, then 09:45 bar close 82.08 โ€” a sharp upward reversal vs prior day.

Recent 30-day range high is 86.38 and low is 64.64 (from indicators). Price on 11-05 was near lower third; 11-06 spike moves price above SMA-5 (68.34) but below SMA-20 (71.80) and SMA-50 (79.68).

Support
67.33
Resistance
86.38
Observed Gap
76.50
SMA-50
79.68
Low 11-06
76.50

Technical Analysis

Technical Indicators

RSI (14)
46.90
MACD
-3.47
Signal
-2.78
Hist
-0.69
SMA 5
68.34
SMA 20
71.80
SMA 50
79.68
ATR 14
3.81
BB Mid
71.80
BB Up
79.76
BB Low
63.83
  • Price below SMA-20 (71.80) and SMA-50 (79.68); SMA-5 (68.34) below both โ€” bearish alignment on daily through 11-05.
  • RSI 46.90 shows neutral-to-soft momentum, not oversold.
  • MACD -3.47 below signal -2.78, histogram -0.69 = bearish momentum persisting.
  • Bollinger mid 71.80, upper 79.76, lower 63.83; 11-05 close 68.88 inside lower half, not a squeeze.
  • 30-day high 86.38, low 64.64; 11-05 close 68.88 = 24.5% above low, 79.9% below high.
  • 11-06 minute bars show recovery above SMA-5 but confirmation lacking on daily close.

True Sentiment Analysis (Delta 40-60 Options)

From tru-sentiment options data (Delta 40-60 only):

Call Volume: 142,400.00 (87.60%) Put Volume: 20,100.00 (12.40%) Total: 162,500.00

  • Sentiment flagged Bullish with 118 call contracts vs 31 put contracts.
  • Call dollar volume conviction strongly exceeds puts by ~7x.
  • Pure directional read suggests near-term upside expectation into 2026-12-18.
  • Divergence: options bullish while MACD/RSI/SMA alignment remain bearish on 11-05 data.
Note: Options flow shows heavy call buying at Delta 40-60 filter; only 26 of 920 options analyzed met criteria (2.80%).

Key Price Levels (Observational Only)

Daily Low 11-05
67.33
BB Lower
63.83
SMA 20
71.80
SMA 50
79.68
30d High
86.38

Interactive charts load with JavaScript. This text is the crawlable summary.